Literature DB >> 21310415

Burden of subclinical cardiovascular disease in "metabolically benign" and "at-risk" overweight and obese women: the Study of Women's Health Across the Nation (SWAN).

Unab I Khan1, Dan Wang, Rebecca C Thurston, Maryfran Sowers, Kim Sutton-Tyrrell, Karen A Matthews, Emma Barinas-Mitchell, Rachel P Wildman.   

Abstract

BACKGROUND: Metabolically benign obese individuals have a 10-year cardiovascular disease (CVD) risk comparable to healthy normal weight individuals. However, the burden of subclinical CVD among metabolically benign obese is not well known.
METHODS: In cross-sectional analyses of 475 mid-life women, we compared common carotid artery intima media thickness (CCA-IMT), aortic pulse wave velocity (aPWV) and coronary (CAC) and aortic calcification (AC) among three groups: healthy normal weight, metabolically benign overweight/obese (<3 metabolic syndrome components/elevated CRP), and at-risk overweight/obese (≥3 metabolic syndrome components/elevated CRP).
RESULTS: The mean (SD) CCA-IMT and aPWV were lowest in the normal weight group (n=145), followed by the benign overweight/obese (n=260) and at-risk overweight/obese (n=70) groups [CCA-IMT: 0.64 (0.08) vs. 0.68 (0.09) vs. 0.73 (0.13) mm, p<0.001; aPWV: 731.0 (176.4) vs. 809.9 (182.3) vs. 875.7 (228.8) cm/s, p<0.001]. Similar results were found for the frequency (%) of women with increased CAC and AC [CAC: 13 (9%) vs. 53(20%) vs. 28(40%), p<0.001; AC: 47(32%) vs. 130 (50%) vs. 55(79%), p<0.001]. These differences remained significant after multivariable adjustment. Further adjustment for BMI attenuated the statistical significance of differences in aPWV and calcification between benign and at-risk overweight/obese women, but had little effect on the magnitude of these differences.
CONCLUSIONS: Metabolically benign overweight/obese women have a significantly greater subclinical CVD burden than normal weight women, despite published data finding similar CVD event rates between the two groups. Prospective studies tracking the progression of subclinical atherosclerosis to clinical CVD in these women are needed.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21310415      PMCID: PMC3117052          DOI: 10.1016/j.atherosclerosis.2011.01.007

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  25 in total

1.  AHA Conference Proceedings. Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: executive summary. American Heart Association.

Authors:  S C Smith; P Greenland; S M Grundy
Journal:  Circulation       Date:  2000 Jan 4-11       Impact factor: 29.690

2.  Quantification of coronary artery calcium using ultrafast computed tomography.

Authors:  A S Agatston; W R Janowitz; F J Hildner; N R Zusmer; M Viamonte; R Detrano
Journal:  J Am Coll Cardiol       Date:  1990-03-15       Impact factor: 24.094

Review 3.  Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

Authors: 
Journal:  Obes Res       Date:  1998-09

4.  Racial differences in coronary artery calcification in older adults.

Authors:  Anne B Newman; Barbara L Naydeck; Jeff Whittle; Kim Sutton-Tyrrell; Daniel Edmundowicz; Lewis H Kuller
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-03-01       Impact factor: 8.311

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 6.  Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.

Authors:  B L Wajchenberg
Journal:  Endocr Rev       Date:  2000-12       Impact factor: 19.871

7.  Measurement variation of aortic pulse wave velocity in the elderly.

Authors:  K Sutton-Tyrrell; R H Mackey; R Holubkov; P V Vaitkevicius; H A Spurgeon; E G Lakatta
Journal:  Am J Hypertens       Date:  2001-05       Impact factor: 2.689

8.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

9.  Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study.

Authors:  Kevin E Kip; Oscar C Marroquin; David E Kelley; B Delia Johnson; Sheryl F Kelsey; Leslee J Shaw; William J Rogers; Steven E Reis
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

10.  Family history of heart attack as an independent predictor of death due to cardiovascular disease.

Authors:  E Barrett-Connor; K Khaw
Journal:  Circulation       Date:  1984-06       Impact factor: 29.690

View more
  34 in total

1.  Cardiovascular disease risk of abdominal obesity vs. metabolic abnormalities.

Authors:  Rachel P Wildman; Aileen P McGinn; Juan Lin; Dan Wang; Paul Muntner; Hillel W Cohen; Kristi Reynolds; Vivian Fonseca; MaryFran R Sowers
Journal:  Obesity (Silver Spring)       Date:  2010-08-19       Impact factor: 5.002

2.  The long-term prognosis of heart diseases for different metabolic phenotypes: a systematic review and meta-analysis of prospective cohort studies.

Authors:  Atieh Mirzababaei; Kurosh Djafarian; Hadis Mozafari; Sakineh Shab-Bidar
Journal:  Endocrine       Date:  2019-01-22       Impact factor: 3.633

3.  Progression from metabolically benign to at-risk obesity in perimenopausal women: a longitudinal analysis of study of women across the nation (SWAN).

Authors:  Unab I Khan; Dan Wang; Carrie A Karvonen-Gutierrez; Naila Khalil; Kelly R Ylitalo; Nanette Santoro
Journal:  J Clin Endocrinol Metab       Date:  2014-05-20       Impact factor: 5.958

4.  Metabolically healthy obesity and metabolically obese normal weight: a review.

Authors:  Saioa Gómez-Zorita; Maite Queralt; Maria Angeles Vicente; Marcela González; María P Portillo
Journal:  J Physiol Biochem       Date:  2021-03-11       Impact factor: 4.158

5.  The adipokine profile of metabolically benign obese and at-risk normal weight postmenopausal women: the Women's Health Initiative Observational Study.

Authors:  Unab I Khan; Alexandra D Ogorodnikova; Linzhi Xu; Dan Wang; Sylvia Wassertheil-Smoller; Gloria Y F Ho; Mary Fran R Sowers; Swapnil N Rajpathak; Matthew A Allison; Rachel H Mackey; Mara Z Vitolins; Joann E Manson; Rachel P Wildman
Journal:  Obesity (Silver Spring)       Date:  2013-12-20       Impact factor: 5.002

Review 6.  The "New Deadly Quartet" for cardiovascular disease in the 21st century: obesity, metabolic syndrome, inflammation and climate change: how does statin therapy fit into this equation?

Authors:  Michael Clearfield; Melissa Pearce; Yasmin Nibbe; David Crotty; Alesia Wagner
Journal:  Curr Atheroscler Rep       Date:  2014-01       Impact factor: 5.113

Review 7.  Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications.

Authors:  Shilpa N Bhupathiraju; Frank B Hu
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

8.  Neonatal morbidities among full-term infants born to obese mothers.

Authors:  Shantanu Rastogi; Mary Rojas; Deepa Rastogi; Shoshana Haberman
Journal:  J Matern Fetal Neonatal Med       Date:  2014-07-11

9.  Ectopic fat and adipokines in metabolically benign overweight/obese women: the Kronos Early Estrogen Prevention Study.

Authors:  Alexandra D Ogorodnikova; Unab I Khan; Aileen P McGinn; Irfan Zeb; Matthew J Budoff; S M Harman; Virginia M Miller; Eliot A Brinton; JoAnn E Manson; Howard N Hodis; George R Merriam; Marcelle I Cedars; Hugh S Taylor; Frederick Naftolin; Rogerio A Lobo; Nanette Santoro; Rachel P Wildman
Journal:  Obesity (Silver Spring)       Date:  2013-05-13       Impact factor: 5.002

Review 10.  Metabolically healthy obesity: definitions, determinants and clinical implications.

Authors:  Catherine M Phillips
Journal:  Rev Endocr Metab Disord       Date:  2013-09       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.